Φορτώνει......
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as of May 8, 2020. Currently, there are no specific COVID-19 therapies. Most patients depend on mechanical ventilation. Current...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Rep Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7190525/ https://ncbi.nlm.nih.gov/pubmed/32562483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100016 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|